Its principal mode of action is thought to be protecting anti-tumor T cells from inhibition by tumor surface-expressed PD-L1.1,2 We recently reported that PD-L1 also mediates important cell-intrinsic signals that regulate immune-independent tumor growth, mTOR signaling and autophagy in melanoma and ovarian cancer cells.3 Tumor-intrinsic PD-L1 also regulates tumor glucose metabolism regulation, affecting anti-tumor T cells.4 Thus, cell-intrinsic PD-L1 signals merit further studies. The gene discussed is MTOR; the disease is neoplasm.